four
new
tetromycin
deriv
tetromycin
previous
known
one
tetromycin
b
isol
streptomyc
axinella
cultiv
mediterranean
spong
axinella
polypoid
structur
assign
use
extens
nmr
spectroscopi
well
hresim
analysi
compound
test
mar
drug
antiparasit
activ
leishmania
major
trypanosoma
brucei
proteas
inhibit
sever
cystein
proteas
falcipain
rhodesain
cathepsin
l
cathepsin
b
viral
proteas
sarscov
pro
pl
pro
compound
show
antiparasit
activ
brucei
timedepend
inhibit
cathepsin
llike
proteas
k
valu
low
micromolar
rang
protozoan
diseas
malaria
leishmaniasi
african
south
american
trypanosomiasi
afflict
million
peopl
particularli
mani
tropic
subtrop
countri
coronavirus
also
import
pathogen
mainli
caus
respiratori
enter
diseas
human
exampl
sarscov
caus
sever
acut
respiratori
syndrom
sar
result
epidem
death
case
worldwid
increas
resist
current
therapi
toxic
exist
drug
aggrav
preval
infecti
diseas
issu
thu
necessit
need
altern
therapi
promis
strategi
develop
new
drug
target
parasit
cystein
proteas
crucial
growth
differenti
pathogen
exampl
proteolyt
enzym
rhodesain
trypanosoma
rhodesiens
falcipain
plasmodium
falciparum
cystein
cathepsin
leishmania
spp
moreov
coronaviru
main
proteas
pro
also
name
proteas
pro
well
papainlik
proteas
sarscov
pl
pro
also
consid
major
target
new
antivir
drug
sar
coronaviru
infect
marin
spong
prolif
sourc
bioactiv
metabolit
marin
environ
differ
natur
product
far
isol
marin
spong
associ
bacteria
new
metabolit
report
spong
annual
owe
filterfeed
capac
frequent
presenc
massiv
amount
microbi
symbiot
consortia
mesohyl
tissu
spong
also
rich
sourc
microorgan
mani
produc
interest
bioactiv
cultiv
effort
focus
particularli
actinomycet
taxonom
clade
respons
product
half
discov
antibiot
date
recent
describ
isol
new
actinomycet
speci
streptomyc
axinella
type
strain
cultiv
mediterranean
spong
axinella
polypoid
isol
new
tetromycin
deriv
unpreced
inhibitori
activ
sever
clinic
import
cystein
proteas
report
choic
use
cystein
proteas
possibl
target
enzym
base
tetron
acid
moieti
part
isol
metabolit
due
lacton
ring
doubl
bond
activ
nucleophil
attack
electron
withdraw
substitu
moieti
predestin
inhibit
cystein
proteas
streptomyc
axinella
grown
ms
agar
secondari
metabolit
extract
ethyl
acet
hplc
fraction
yield
five
compound
tetromycin
tetromycin
b
hresim
extens
nmr
analysi
tabl
suggest
compound
new
constitut
isom
sever
tetromycin
previous
isol
streptomyc
sp
strain
tetromycin
display
pseudomolecular
ion
posit
esim
spectrum
mz
na
correspond
molecular
formula
c
h
isomer
tetromycin
ir
spectra
tetromycin
show
expect
absorpt
band
hydroxi
group
cm
acid
function
cm
carbonyl
group
cm
conjug
carbonyl
group
cm
ccdoubl
bond
cm
aromat
ring
cm
presenc
function
group
support
h
c
dept
nmr
data
carbonproton
connect
unambigu
assign
hsqc
experi
four
compound
c
nmr
indic
presenc
twotim
hydroxyalkoxysubstitut
aromat
moieti
made
carbon
correspond
signal
h
nmr
spectra
show
two
aromat
proton
metaposit
aromat
ring
see
tabl
shift
multipl
coupl
constant
hmbc
correl
methyl
group
proton
carbonyl
aromat
ring
confirm
addit
orthosubstitut
pattern
cosi
interact
one
aromat
proton
left
open
substitut
aromat
carbon
shift
ppm
indic
hydroxi
alkoxi
substitu
locat
posit
tetromycin
hydroxi
group
methyl
evid
correl
methoxi
group
proton
hmbc
spectrum
contrast
compound
hydroxyl
carri
methoxi
group
compound
hydroxi
group
clearli
indic
hmbc
c
h
data
figur
hmbc
correl
tetromycin
reveal
connect
aromat
ring
pyran
fragment
via
ester
amid
bond
respect
figur
substitut
pattern
moieti
unambigu
establish
hmbc
roesi
data
connect
pyran
group
decalin
ring
system
consist
via
acet
paraposit
esteramid
junction
detect
bilater
hmbc
correl
carbon
proton
figur
far
describ
fragment
agreement
publish
structur
tetromycin
main
differ
tetromycin
previous
isol
congen
cover
patent
lie
presenc
doubl
bond
instead
state
tetromycin
decalin
ring
system
posit
methyl
group
instead
follow
detail
nmr
correl
account
alter
posit
exemplarili
discuss
tetromycin
use
select
key
nmr
interact
figur
hsqc
spectra
show
two
diastereotop
proton
attach
strong
roesi
cosi
correl
correl
coupl
constant
suggest
jcoupl
direct
connect
hmbc
correl
methyl
carbon
two
vinyl
carbon
latter
presum
carri
methyl
group
agreement
higher
shift
accord
hmbc
signal
methyl
proton
show
three
strong
correl
vinyl
carbon
also
suggest
posit
methyl
group
describ
earlier
conclus
substanti
strong
hmbc
correl
vinyl
proton
close
first
sixmemb
ring
decalin
system
directli
connect
evidenc
direct
cosi
interact
hmbc
correl
also
correl
proton
turn
show
hmbc
correl
look
correspond
c
nmr
shift
cc
doubl
bond
could
locat
second
sixmemb
ring
decalin
system
specif
featur
previous
describ
compound
hmbc
c
h
data
confirm
result
thu
discov
seri
tetromycin
deriv
possess
doubl
bond
methyl
group
remain
partial
structur
compound
turn
accord
alreadi
publish
compound
interestingli
tetromycin
exhibit
molecular
ion
posit
esim
spectrum
mz
h
correspond
molecular
formula
c
h
found
complet
new
deriv
differ
found
decalin
ring
system
made
addit
cyclohexen
fragment
carri
acid
group
figur
seen
tetromycin
hsqc
data
tetromycin
reveal
two
diastereotop
proton
locat
hmbc
correl
account
singl
bond
discuss
howev
compound
also
show
strong
hmbc
correl
vinyl
proton
suggest
close
proxim
carbon
chunit
accord
dept
data
furthermor
correl
methyl
group
interestingli
also
reinforc
proposit
assign
instead
found
isol
compound
unobserv
tetromycin
methyl
group
proton
correl
also
bridg
atom
sixmemb
ring
decalin
system
lead
undoubt
conclus
methyl
group
posit
second
sixmemb
ring
featur
satur
carbon
atom
discuss
tetromycin
deriv
possess
cyclohexen
fragment
made
bridg
atom
adjac
ring
system
carri
acid
function
group
ccdoubl
bond
present
alreadi
describ
publish
patent
bridg
atom
publish
compound
compound
quaternari
carbon
carri
methyl
group
see
tabl
respect
shift
unmistak
reveal
cosi
coupl
hmbc
correl
figur
unambigu
confirm
posit
cyclohexen
carbon
tetromycin
none
name
correl
methyl
group
could
found
furthermor
show
lower
shift
compound
appear
ch
dept
spectrum
loss
methyl
group
accord
observ
lower
molecular
mass
also
indic
formal
loss
ch
fragment
compar
compound
therefor
report
discoveri
new
tetromycin
deriv
featur
doubl
bond
methyl
substitu
hydrogen
lastli
compound
found
ident
tetromycin
b
mz
na
correspond
molecular
formula
c
h
figur
show
structur
tetromycin
tetromycin
b
compound
test
parasit
leishmania
major
trypanosoma
brucei
subsp
brucei
cytotox
kidney
epitheli
cell
macrophag
tabl
antileishmania
activ
found
tetromycin
five
compound
exhibit
antitrypanosoma
activ
h
time
point
judg
ic
valu
compound
also
show
cytotox
activ
ic
kidney
cell
line
macrophag
notabl
except
tetromycin
compound
subject
proteas
inhibit
assay
mammalian
proteas
cathepsin
b
l
parasit
cathepsinl
like
proteas
p
falciparum
rhodesain
brucei
rhodesiens
coronavir
papainlik
proteas
sarscov
pl
pro
well
coronavir
main
proteas
sarscov
pro
initi
screen
assay
perform
compound
concentr
second
step
compound
show
enzym
inhibit
concentr
compound
analyz
detail
substrat
hydrolysi
monitor
min
absenc
presenc
variou
inhibitor
concentr
seven
inhibitor
concentr
span
zero
total
inhibit
respect
enzym
interestingli
inhibit
cathepsin
llike
proteas
observ
timedepend
inhibit
cathepsin
b
coronavir
papainlik
proteas
figur
compound
inact
weakli
activ
inhibit
sarscov
pro
case
timedepend
inhibit
pseudofirst
order
rate
constant
inhibit
k
ob
obtain
progress
curv
fit
inhibitor
concentr
obtain
k
k
final
k
valu
figur
see
experiment
section
detail
order
ascertain
inhibit
competit
respect
substrat
determin
k
valu
inhibit
rhodesain
tetromycin
b
three
differ
substrat
concentr
found
signific
differ
indic
competit
inhibit
interestingli
timedepend
inhibit
found
cathepsinl
like
enzym
cathepsin
b
coronavir
proteas
pl
pro
observ
timedepend
inhibit
could
either
due
irrevers
inhibit
mechan
result
coval
reaction
reactiv
moieti
inhibitor
tetron
acid
contain
lacton
ring
cystein
residu
activ
site
target
proteas
slowbind
mechan
result
conform
chang
enzymeinhibitor
complex
reason
differ
cathepsinl
like
proteas
mammalian
cathepsin
l
falcipain
rhodesain
other
yet
clear
requir
detail
studi
smaller
synthet
deriv
contain
tetron
acid
moieti
inact
sarscov
pro
cystein
proteas
differ
target
proteas
proton
state
activ
site
cysshhi
instead
ion
pair
cyss
hish
threedimension
fold
similar
serin
proteas
chymotrypsin
instead
papainlik
fold
show
compound
unselect
frequent
hitter
also
support
hypothesi
compound
coval
inhibitor
cathepsinl
like
proteas
sinc
activ
centr
proteas
nucleophil
thu
better
capabl
reaction
tetron
acid
moieti
inhibit
constant
k
valu
k
valu
differ
larg
three
compound
indic
common
inhibit
mechan
tabl
summar
inhibit
constant
compound
rd
k
k
min
fp
k
k
min
cl
k
k
min
cb
k
k
high
resolut
esim
analys
perform
micromass
qtof
micro
mass
spectromet
nmr
spectra
obtain
varian
inova
h
mhz
c
mhz
varian
inova
h
mhz
c
mhz
spectromet
mm
nalorac
mdbg
probe
mm
cold
probe
respect
uv
spectra
acquir
spectroscopi
grade
meoh
use
hewlettpackard
diod
array
spectrophotomet
ir
spectra
record
use
jasco
spectrophotomet
hplc
perform
agil
system
use
luna
c
phenomenex
inc
mm
column
streptomyc
axinella
strain
cultiv
mediterranean
spong
axinella
polypoid
spong
collect
scuba
dive
offshor
banyulssurm
franc
gp
n
streptomyc
axinella
strain
deposit
deutsch
sammlung
von
mikroorganismen
und
zellkulturen
gmbh
dsmz
collect
de
linstitut
pasteur
cip
bacteri
strain
grown
ms
agar
plate
seven
day
myceli
mass
togeth
agar
cut
small
piec
macer
overnight
suffici
volum
ethyl
acet
fulli
submerg
biomass
result
solut
filter
macer
ethyl
acet
repeat
filtrat
combin
dri
rotari
evapor
isol
compound
carri
semiprepar
hplc
use
h
tfa
ch
cn
b
solvent
follow
gradient
flow
mlmin
min
b
min
b
yield
five
compound
tetromycin
mg
rt
min
tetromycin
mg
rt
min
tetromycin
mg
rt
min
tetromycin
mg
rt
min
tetromycin
b
mg
rt
min
leishmania
major
promastigot
seed
cell
densiti
cellsml
plate
complet
medium
rpmi
nahco
fc
mm
glutamin
mm
hepe
ph
uml
penicillin
gentamicin
mm
without
phenol
red
ml
absenc
presenc
differ
concentr
compound
incub
h
co
humid
follow
addit
alamar
blue
plate
incub
optic
densiti
od
measur
h
later
enzymelink
immunosorb
assay
elisa
reader
multiskan
ascent
germani
use
test
wavelength
nm
refer
wavelength
nm
absorb
absenc
compound
set
growth
amphotericin
b
use
refer
compound
posit
control
effect
cell
densiti
incub
time
concentr
dmso
examin
control
experi
final
concentr
dmso
medium
never
exceed
volvol
effect
prolifer
extracellular
intracellular
parasit
everi
experi
drug
concentr
assay
duplic
well
trypomastigot
form
trypanosoma
brucei
subsp
brucei
laboratori
strain
tc
cultur
complet
baltz
medium
ml
baltz
medium
basic
solut
ml
stock
solut
mm
ml
penicillinstreptomycin
uml
ml
fc
inactiv
min
baltz
medium
basic
solut
compos
follow
ml
mem
earl
salt
lglutamin
g
hepe
g
monohydr
glucos
g
sodium
pyruv
g
hypoxanthin
g
thymidin
g
adenosin
g
bathocuproinedisulfon
acid
disodium
salt
g
glutamin
ml
steril
nonessenti
amino
acid
concentr
ph
defin
number
parasit
trypanosom
per
ml
test
chamber
plate
expos
variou
concentr
test
substanc
dissolv
dmso
make
final
volum
duplic
posit
trypanosom
cultur
medium
neg
control
test
substanc
without
trypanosom
run
simultan
plate
plate
incub
atmospher
co
total
time
period
h
h
alamar
blue
ad
activ
test
substanc
measur
light
absorpt
use
mr
micropl
reader
wavelength
nm
refer
wavelength
nm
first
read
done
h
subsequ
h
effect
test
substanc
quantifi
ic
valu
linear
interpol
three
independ
measur
macrophag
cultur
complet
medium
rpmi
nahco
fc
mm
glutamin
mm
hepe
ph
uml
penicillin
gentamicin
without
phenol
red
absenc
presenc
increas
concentr
compound
cell
densiti
cellsml
h
co
humid
follow
addit
alamar
blue
plate
incub
od
measur
h
alamar
blue
assay
previous
describ
leishmania
follow
kidney
epitheli
cell
test
manner
macrophag
use
complet
dmem
medium
gl
solut
dmem
high
glucos
solut
sodium
pyruv
without
lglutamin
fb
superior
final
concentr
mm
lglutamin
cell
densiti
cellsml
fluorometr
enzym
assay
perform
cari
eclips
fluoresc
spectrophotomet
varian
darmstadt
germani
use
micropl
reader
excit
nm
emiss
nm
cathepsin
b
l
proteas
inhibit
assay
perform
mm
trishcl
buffer
ph
contain
mm
edta
mm
dtt
mm
nacl
brij
describ
vicik
et
al
assay
rhodesain
perform
mm
acet
buffer
ph
mm
dtt
mm
edta
mm
nacl
brij
substrat
cbzpheargamc
four
enzym
inhibitor
stock
solut
prepar
dmso
final
concentr
dilut
assay
buffer
final
substrat
concentr
inhibit
assay
show
timedepend
inhibit
progress
curv
fit
exponenti
equat
limit
exp
ob
offset
yield
pseudofirst
order
rate
inhibit
k
ob
fit
inhibitor
concentr
k
ob
k
k
app
yield
k
k
app
k
app
valu
correct
zero
substrat
concentr
k
k
app
k
k
calcul
k
k
k
k
valu
use
correct
k
app
valu
determin
previou
work
rd
cl
cb
sarscov
pl
pro
program
grafit
erithacu
softwar
ltd
version
use
calcul
inhibit
constant
result
present
herein
highlight
import
marin
actinomycet
drug
discoveri
shown
identif
four
structur
new
tetromycin
deriv
previous
known
compound
tetromycin
b
marin
spongederiv
isol
streptomyc
axinella
antiparasit
activ
caus
agent
african
sleep
diseas
trypansoma
brucei
report
furthermor
compound
show
timedepend
inhibit
cathepsin
llike
proteas
k
valu
low
micromolar
rang
select
cathepsinlik
enzym
give
good
start
point
studi
aim
elucid
moieti
inhibitor
respons
inhibit
probabl
tetron
acid
moieti
improv
select
mammalian
parasit
enzym
may
lead
less
cytotox
enhanc
inhibit
potenc
furthermor
addit
target
within
parasit
taken
account
trypanosoma
brucei
eg
cathepsinb
like
proteas
tbcatb
also
known
essenti
parasit
life
cycl
activ
proteas
could
contribut
antiparasit
activ
compound
final
futur
work
also
address
stereochem
aspect
